Patents/Assignees

Starton Therapeutics, Inc.

4 patents in portfolio

US12390457utility2025
Stable Solutions of Immunomodulatory Imide Compounds for Parenteral Use
0 cites
US12383510utility2025
Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine
0 cites
US12201622utility2025
Continuous Delivery of Lenalidomide and Other Immunomodulatory Agents
0 cites
US11975112utility2024
Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine
0 cites